A Study of Neurofeedback for the Treatment of Parkinson's Disease
NCT ID: NCT03837548
Last Updated: 2019-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2019-06-01
2022-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurofeedback Training for PD
NCT05987865
Real-time fMRI Neurofeedback for Treatment of Parkinson's Disease
NCT01867827
The Effects of fNIRS-based Neurofeedback Training on Balance and Gait in Parkinson's Disease
NCT05800470
Effect of Mental Imagery Training on Brain Plasticity and Motor Function in Individuals With Parkinson's Disease
NCT03623386
FMRI-neurofeedback in Parkinson's Disease
NCT06582355
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Training with Neurofeedback
Training with Neurofeedback
Neurofeedback the brain activities by Magnetoencephalography
The other Training with Neurofeedback
The other Training with Neurofeedback
Neurofeedback the brain activities by Magnetoencephalography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Training with Neurofeedback
Neurofeedback the brain activities by Magnetoencephalography
The other Training with Neurofeedback
Neurofeedback the brain activities by Magnetoencephalography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects obtained the consent
* Subjects with Parkinson disease and healthy subjects
Exclusion Criteria
* Subjects with severe illness
* Subjects whom the experimenter think as in appropriate
* Subjects with implantable devices such as pacemaker
20 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Japan Agency for Medical Research and Development
OTHER_GOV
Osaka University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Osaka University
Suita, Osaka, Japan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Izutsu N, Yanagisawa T, Fukuma R, Kishima H. Magnetoencephalographic neurofeedback training decreasesbeta-low-gammaphase-amplitude coupling of the motor cortex of healthy adults: a double-blinded randomized crossover feasibility study. J Neural Eng. 2023 May 9;20(3). doi: 10.1088/1741-2552/acd0d6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UMIN000032937
Identifier Type: REGISTRY
Identifier Source: secondary_id
18027-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.